Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
7.39
+0.07 (0.96%)
Apr 30, 2026, 3:04 PM CST

SHE:000919 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
4,5964,9444,1044,0233,9663,856
Market Cap Growth
8.69%20.47%2.02%1.43%2.86%-0.52%
Enterprise Value
3,3583,6302,6443,5033,0763,156
Last Close Price
7.397.956.497.647.457.23
PE Ratio
78.0191.71101.5637.8837.6731.96
Forward PE
-20.2420.2420.2420.2420.24
PS Ratio
1.461.551.251.261.491.37
PB Ratio
0.951.020.850.911.091.09
P/TBV Ratio
1.331.451.211.471.461.39
P/FCF Ratio
31.96302.55---29.83
P/OCF Ratio
19.9028.3826.6218.9715.2213.20
PEG Ratio
-1.011.011.011.011.01
EV/Sales Ratio
1.061.140.811.101.151.12
EV/EBITDA Ratio
19.4721.5614.6915.2417.7210.84
EV/EBIT Ratio
123.47145.41104.4843.3360.2818.65
EV/FCF Ratio
23.35222.11---24.42
Debt / Equity Ratio
0.040.040.040.010.000.01
Debt / EBITDA Ratio
1.111.111.020.180.030.06
Debt / FCF Ratio
11.7411.74---0.13
Net Debt / Equity Ratio
-0.55-0.55-0.51-0.47-0.50-0.42
Net Debt / EBITDA Ratio
-15.79-15.79-13.62-9.04-10.55-5.11
Net Debt / FCF Ratio
-162.62-162.6251.7180.3637.35-11.50
Asset Turnover
0.530.530.570.640.590.64
Inventory Turnover
10.0310.039.529.458.649.46
Quick Ratio
3.643.643.252.692.722.37
Current Ratio
3.893.893.522.983.042.67
Return on Equity (ROE)
1.06%1.06%0.39%3.20%3.18%4.39%
Return on Assets (ROA)
0.26%0.26%0.27%1.01%0.71%2.42%
Return on Invested Capital (ROIC)
0.85%0.86%0.48%3.40%2.37%6.35%
Return on Capital Employed (ROCE)
0.50%0.50%0.50%1.80%1.40%4.70%
Earnings Yield
1.28%1.09%0.98%2.64%2.66%3.13%
FCF Yield
3.13%0.33%-1.16%-0.64%-1.24%3.35%
Dividend Yield
1.37%1.26%1.54%1.31%1.34%1.38%
Payout Ratio
114.49%125.23%156.50%48.17%48.60%42.00%
Buyback Yield / Dilution
-4.95%-4.95%-17.56%-0.01%0.02%0.01%
Total Shareholder Return
-3.58%-3.69%-16.02%1.30%1.36%1.40%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.